The Interplay between Alpha-Synuclein Clearance and Spreading

被引:85
作者
da Fonseca, Tomas Lopes [1 ,2 ]
Villar-Pique, Anna [1 ]
Outeiro, Tiago Fleming [1 ,2 ,3 ]
机构
[1] Univ Med Ctr Gottingen, Dept Neurodegenerat & Restorat Res, Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37073 Gottingen, Germany
[2] Univ Lisbon, Inst Fisiol, Fac Med, P-1649028 Lisbon, Portugal
[3] Univ Nova Lisboa, CEDOC, Fac Ciencias Med, P-1150 Lisbon, Portugal
来源
BIOMOLECULES | 2015年 / 5卷 / 02期
关键词
D O I
10.3390/biom5020435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's Disease (PD) is a complex neurodegenerative disorder classically characterized by movement impairment. Pathologically, the most striking features of PD are the loss of dopaminergic neurons and the presence of intraneuronal protein inclusions primarily composed of alpha-synuclein (alpha-syn) that are known as Lewy bodies and Lewy neurites in surviving neurons. Though the mechanisms underlying the progression of PD pathology are unclear, accumulating evidence suggests a prion-like spreading of alpha-syn pathology. The intracellular homeostasis of alpha-syn requires the proper degradation of the protein by three mechanisms: chaperone-mediated autophagy, macroautophagy and ubiquitin-proteasome. Impairment of these pathways might drive the system towards an alternative clearance mechanism that could involve its release from the cell. This increased release to the extracellular space could be the basis for alpha-syn propagation to different brain areas and, ultimately, for the spreading of pathology and disease progression. Here, we review the interplay between alpha-syn degradation pathways and its intercellular spreading. The understanding of this interplay is indispensable for obtaining a better knowledge of the molecular basis of PD and, consequently, for the design of novel avenues for therapeutic intervention.
引用
收藏
页码:435 / 471
页数:37
相关论文
共 272 条
  • [1] An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation
    Agarraberes, FA
    Terlecky, SR
    Dice, JF
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 137 (04) : 825 - 834
  • [2] Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease
    Alvarez-Erviti, L.
    Seow, Y.
    Schapira, A. H. V.
    Rodriguez-Oroz, M. C.
    Obeso, J. A.
    Cooper, J. M.
    [J]. CELL DEATH & DISEASE, 2013, 4 : e545 - e545
  • [3] Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
    Alvarez-Erviti, Lydia
    Rodriguez-Oroz, Maria C.
    Cooper, J. Mark
    Caballero, Cristina
    Ferrer, Isidro
    Obeso, Jose A.
    Schapira, Anthony H. V.
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (12) : 1464 - 1472
  • [4] Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
    Anderson, John P.
    Walker, Donald E.
    Goldstein, Jason M.
    de laat, Rian
    Banducci, Kelly
    Caccavello, Russell J.
    Barbour, Robin
    Huang, Jiping
    Kling, Kristin
    Lee, Michael
    Diep, Linnea
    Keim, Pamela S.
    Shen, Xiaofeng
    Chataway, Tim
    Schlossmacher, Michael G.
    Seubert, Peter
    Schenk, Dale
    Sinha, Sukanto
    Gai, Wei Ping
    Chilcote, Tamie J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) : 29739 - 29752
  • [5] Regulated secretion of conventional lysosomes
    Andrews, NW
    [J]. TRENDS IN CELL BIOLOGY, 2000, 10 (08) : 316 - 321
  • [6] Membrane repair and immunological danger
    Andrews, NW
    [J]. EMBO REPORTS, 2005, 6 (09) : 826 - 830
  • [7] Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo
    Angot, Elodie
    Steiner, Jennifer A.
    Tome, Carla M. Lema
    Ekstrom, Peter
    Mattsson, Bengt
    Bjorklund, Anders
    Brundin, Patrik
    [J]. PLOS ONE, 2012, 7 (06):
  • [8] OLFACTORY FUNCTION IN PATIENTS WITH PARKINSONS-DISEASE
    ANSARI, KA
    JOHNSON, A
    [J]. JOURNAL OF CHRONIC DISEASES, 1975, 28 (09): : 493 - 497
  • [9] Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
    Appel-Cresswell, Silke
    Vilarino-Guell, Carles
    Encarnacion, Mary
    Sherman, Holly
    Yu, Irene
    Shah, Brinda
    Weir, David
    Thompson, Christina
    Szu-Tu, Chelsea
    Trinh, Joanne
    Aasly, Jan O.
    Rajput, Alex
    Rajput, Ali H.
    Stoessl, A. Jon
    Farrer, Matthew J.
    [J]. MOVEMENT DISORDERS, 2013, 28 (06) : 811 - 813
  • [10] The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease
    Arawaka, Shigeki
    Wada, Manabu
    Goto, Saori
    Karube, Hiroki
    Sakamoto, Masahiro
    Ren, Chang-Hong
    Koyama, Shingo
    Nagasawa, Hikaru
    Kimura, Hideki
    Kawanami, Toru
    Kurita, Keiji
    Tajima, Katsushi
    Daimon, Makoto
    Baba, Masanori
    Kido, Takashi
    Saino, Sachiko
    Goto, Kaoru
    Asao, Hironobu
    Kitanaka, Chihumi
    Takashita, Emi
    Hongo, Seiji
    Nakamura, Takao
    Kayama, Takamasa
    Suzuki, Yoshihiro
    Kobayashi, Kazuo
    Katagiri, Tadashi
    Kurokawa, Katsuro
    Kurimura, Masayuki
    Toyoshima, Itaru
    Niizato, Kazuhiro
    Tsuchiya, Kuniaki
    Iwatsubo, Takeshi
    Muramatsu, Masaaki
    Matsumine, Hiroto
    Kato, Takeo
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (36) : 9227 - 9238